# 4G Clinical

> 4G Clinical supplies cloud software and specialist services for clinical trial randomization, drug assignment, inventory and resupply. Prancer RTSM manages live trial execution; 4C Supply models demand and supply scenarios for biotech, pharmaceutical and CRO teams worldwide.

- **Founded:** 2015
- **Headquarters:** Wellesley, United States
- **Founders:** David Kelleher (Co-founder and CEO), Ed Tourtellotte (Co-founder and board director; founding CTO)
- **Products:** Prancer RTSM, 4C Supply, Prancer Lite, Prancer RTSM Inventory Platform, Prancer Kei
- **Notable:** Reported more than 100 biotech and pharma clients in June 2021., Ranked No. 159 in the 2022 Deloitte Technology Fast 500, with reported revenue growth of 909% over 2018-2021., Announced a growth equity investment agreement of more than $230 million from Goldman Sachs Asset Management in June 2021.

## Products & services

- **Prancer RTSM** — Cloud-based randomization, treatment assignment, inventory, resupply, forecasting and reporting for clinical trials; uses NLP in study configuration.
- **4C Supply** — Clinical supply scenario modeling and demand forecasting; integrates with Prancer, third-party IRT and enterprise data systems.
- **Prancer Lite** — Streamlined RTSM deployment for simpler studies with more defined operational scope.
- **Prancer RTSM Inventory Platform** — Inventory visibility, forecasting and resupply without requiring full randomization deployment.
- **Prancer Kei** — Prancer deployment designed for Japanese language, regulatory and regional operating requirements.
- **Enterprise Prancer Integrations** — Sponsor-level integration configurations reused across studies with monitoring and governance.
- **4G DataHub** — Portfolio-level study data delivery and API-enabled access for sponsor analytics.
- **UltimaRand** — Auditable patient randomization and kit list generation.
- **Study delivery and expert support** — Protocol interpretation, configuration, validation, forecasting, integrations, amendments and ongoing study support.

## Achievements

- Reported more than 100 biotech and pharma clients in June 2021.
- Ranked No. 159 in the 2022 Deloitte Technology Fast 500, with reported revenue growth of 909% over 2018-2021.
- Announced a growth equity investment agreement of more than $230 million from Goldman Sachs Asset Management in June 2021.
- Trust Center reports a SOC 2 report for the twelve months ending August 31, 2025.

## Latest updates

- **2026-08** — Published Supply Had to Respond to Live Reality, arguing for supply planning linked to live study activity.
- **2026-07** — Published The Operational Cost of “We’ll Add That Later”, examining costs of deferring RTSM functionality.
- **2026-01** — David Kelleher discussed NLP, validation, global operations and approximately 400 staff as of late 2025 in an Onyx interview.
- **2025-08** — Trust Center records an EcoVadis Committed Badge assessment and the end of its latest published SOC 2 reporting period.

## Links

- Website: https://www.4gclinical.com/
- LinkedIn: https://www.linkedin.com/company/4g-clinical/
- Twitter/X: https://twitter.com/4gclinical
- Facebook: https://www.facebook.com/4gclinical/

---

Profile page: https://yespress.io/4g-clinical
Published by YesPress — https://yespress.io
Last updated: 2026-10-02